NCT01648660|Completed
Loading search results
Sponsor study identifier
interventional
80
0 countries
N/A
Study Start
May 2009
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2012
Actual (reported)Study Completion
December 2012
Actual (reported)The primary objective of LUTEGA 2 is it to determine the long term effect (about 2 more years after LUTEGA 1, NCT00763659) of the supplementation with a fixed combination of lutein/zeaxanthin and omega-3- fatty acids in two different dosages on the optical density (OD) of macular pigment in patients with non- exudative age related maculopathy. The dosage groups are crossed after LUTEGA 1.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2012
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 2009
Date type not reportedThis date has not been verified as actual or estimated.
July 19, 2012
Actual (reported)July 24, 2012
Actual (reported)December 2012
Actual (reported)December 2012
Actual (reported)Optical density of macular pigment
24 months
Cross Over from double dosage to single dosage: daily supplementation with 10mg Lutein, 1mg Zeaxanthin, 255 mg Omega-3-FAabout two years after one year with 20mg Lutein, 2mg Zeaxanthin, 510 mg Omega-3-FA
Cross Over from double dosage to single dosage: daily supplementation with 20mg Lutein, 2mg Zeaxanthin, 510 mg Omega-3-FA about two years after one year with 10mg Lutein, 1mg Zeaxanthin, 255 mg Omega-3-FA
capsule with Lutein, Zeaxanthin, Omega-3-FA for two years
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Jürgen Strobel, MD
University Hospital Jena
Jens Dawczynski, MD
University of Leipzig
80 participants (actual enrollment reported by the registry).
First Submitted
July 19, 2012
First Posted
July 24, 2012
Study Start
May 2009
Date type not reportedThis date has not been verified as actual or estimated.
Consumption of Eggs Rich in Lutein and Omega-3 Fatty Acids on the Macular Pigment
single dosage: daily supplementation about two years after one year with 10mg Lutein, 1mg Zeaxanthin, 255 mg Omega-3-FA (dosage remains existing)
Contact the study team to confirm eligibility.
Primary Completion
December 2012
Actual (reported)Study Completion
December 2012
Actual (reported)Last Updated
January 10, 2013
Record last verified: 2013-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: